Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04026230
Title Impact of Atorvastatin on Prostate Cancer Progression During ADT (ESTO2)
Acronym ESTO2
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Tampere University Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries NOR | FIN | EST | DNK


No variant requirements are available.